Fri, February 2, 2018

Matthew Harrison Maintained (AMGN) at Buy with Decreased Target to $196 on, Feb 2nd, 2018

Matthew Harrison of Morgan Stanley, Maintained "Amgen Inc." (AMGN) at Buy with Decreased Target from $204 to $196 on, Feb 2nd, 2018.

Matthew has made no other calls on AMGN in the last 4 months.



There are 3 other peers that have a rating on AMGN. Out of the 3 peers that are also analyzing AMGN, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Cory Kasimov of "JP Morgan" Maintained at Hold with Increased Target to $189 on, Wednesday, January 24th, 2018
  • Geoff Meacham of "Barclays" Maintained at Hold with Increased Target to $190 on, Friday, October 13th, 2017


This is the rating of the analyst that currently disagrees with Matthew


  • David Toung of "Argus Research" Upgraded from Hold to Strong Buy and Held Target at $220 on, Tuesday, January 23rd, 2018